EDGAR Filing Documents for 0001193125-17-198596

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-17-198596

Filing Date

2017-06-08

Accepted

2017-06-08 16:49:37

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-3	d411412ds3.htm	S-3	376522
2	EX-4.6	d411412dex46.htm	EX-4.6	95097
3	EX-4.7	d411412dex47.htm	EX-4.7	95899
4	EX-4.8	d411412dex48.htm	EX-4.8	95895
5	EX-4.10	d411412dex410.htm	EX-4.10	314649
6	EX-5.1	d411412dex51.htm	EX-5.1	24175
7	EX-23.1	d411412dex231.htm	EX-23.1	2133
8	GRAPHIC	g411412g0607120701264.jpg	GRAPHIC	1858
9	GRAPHIC	g411412g0608122112789.jpg	GRAPHIC	2722
	Complete submission text file	0001193125-17-198596.txt		1012132

Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500

SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)